{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T09:23:36Z","timestamp":1788168216776,"version":"build-2803163510"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-026-01133-z","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:45:40Z","timestamp":1787762740000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lipid-coated mesoporous silica nanoparticles loaded with Thymoquinone as a novel treatment for experimental autoimmune encephalomyelitis in rats"],"prefix":"10.1186","volume":"27","author":[{"given":"Heba M.","family":"Fahmy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amena S.","family":"El-Feky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa M.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman S.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Engy","family":"Shams-Eldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiseer M.","family":"Abd El-Daim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira B.","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai W.","family":"Abd Alrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faten F.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed M.","family":"Fathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"issue":"7","key":"1133_CR1","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/J.ANNEPIDEM.2011.03.001","volume":"21","author":"N Palacios","year":"2011","unstructured":"Palacios N, Alonso A, Br\u00d8nnum-Hansen H, Ascherio A. Smoking and increased risk of Multiple Sclerosis: parallel trends in the sex ratio reinforce the evidence. Ann Epidemiol. 2011;21(7):536\u201342. https:\/\/doi.org\/10.1016\/J.ANNEPIDEM.2011.03.001.","journal-title":"Ann Epidemiol"},{"issue":"8","key":"1133_CR2","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1177\/1352458517694432","volume":"23","author":"G Kobelt","year":"2017","unstructured":"Kobelt G, Thompson A, Berg J, Gannedahl M, Eriksson J. New insights into the burden and costs of Multiple Sclerosis in Europe. Mult Scler. 2017;23(8):1123\u201336. https:\/\/doi.org\/10.1177\/1352458517694432.","journal-title":"Mult Scler"},{"issue":"12","key":"1133_CR3","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/J.AMJMED.2020.05.049","volume":"133","author":"SL Hauser","year":"2020","unstructured":"Hauser SL, Cree BAC. Treatment of Multiple Sclerosis: a Review. Am J Med. 2020;133(12):1380\u201390.e2. https:\/\/doi.org\/10.1016\/J.AMJMED.2020.05.049.","journal-title":"Am J Med"},{"issue":"13","key":"1133_CR4","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1177\/1352458518803785","volume":"24","author":"R Kalb","year":"2018","unstructured":"Kalb R, Beier M, Benedict RH, Charvet L, Costello K, Feinstein A, et al. Recommendations for Cognitive screening and management in Multiple Sclerosis Care. Mult Scler. 2018;24(13):1665\u201380. https:\/\/doi.org\/10.1177\/1352458518803785.","journal-title":"Mult Scler"},{"issue":"October","key":"1133_CR5","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/J.SEMCDB.2019.05.004","volume":"94","author":"CS Subhramanyam","year":"2019","unstructured":"Subhramanyam CS, Wang C, Hu Q, Dheen ST. Microglia-Mediated Neuroinflammation in Neurodegenerative Diseases. Semin Cell Dev Biol. 2019;94(October):112\u201320. https:\/\/doi.org\/10.1016\/J.SEMCDB.2019.05.004.","journal-title":"Semin Cell Dev Biol"},{"issue":"6","key":"1133_CR6","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/JOIM.13215","volume":"289","author":"F Piehl","year":"2021","unstructured":"Piehl F. Current and emerging disease-modulatory Therapies and treatment Targets for Multiple Sclerosis. J Intern Med. 2021;289(6):771\u201391. https:\/\/doi.org\/10.1111\/JOIM.13215.","journal-title":"J Intern Med"},{"key":"1133_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/1062562","volume":"2018","author":"J Jiang","year":"2018","unstructured":"Jiang J, Pi J, Cai J. The Advancing of Zinc oxide nanoparticles for Biomedical Applications[1], \u2018The Advancing of Zinc Oxide Nanoparticles for Biomedical Applications,\u2019 vol. Bioinorg Chem Appl 2018. 2018;2018:1\u201318. https:\/\/doi.org\/10.1155\/2018\/1062562.","journal-title":"Bioinorg Chem Appl 2018"},{"key":"1133_CR8","doi-asserted-by":"publisher","unstructured":"Yang C, Hawkins KE, Dor\u00e9 S, Candelario-Jalil E. Neuroinflammatory mechanisms of blood-brain Barrier damage in ischemic stroke. Am J Physiol-Cell Physiol. 2019;316(2):C135\u201353. https:\/\/doi.org\/10.1152\/ajpcell.00136.2018.","DOI":"10.1152\/ajpcell.00136.2018"},{"issue":"6","key":"1133_CR9","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/JNR.24224","volume":"96","author":"I Bjelobaba","year":"2018","unstructured":"Bjelobaba I, Begovic-Kupresanin V, Pekovic S, Lavrnja I. Animal models of Multiple Sclerosis: focus on Experimental autoimmune Encephalomyelitis. J Neurosci Res. 2018;96(6):1021\u201342. https:\/\/doi.org\/10.1002\/JNR.24224.","journal-title":"J Neurosci Res"},{"issue":"5","key":"1133_CR10","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jobaz.2014.08.005","volume":"67","author":"HM Fahmy","year":"2014","unstructured":"Fahmy HM, Noor NA, Mohammed FF, Elsayed AA, Radwan NM. Nigella Sativa as an anti-inflammatory and promising remyelinating agent in the cortex and hippocampus of Experimental autoimmune Encephalomyelitis-induced rats. J Sport Hist Basic Appl Zool. 2014;67(5):182\u201395. https:\/\/doi.org\/10.1016\/j.jobaz.2014.08.005.","journal-title":"J Sport Hist Basic Appl Zool"},{"issue":"3","key":"1133_CR11","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1177\/1352458518805246","volume":"25","author":"DJ Burrows","year":"2019","unstructured":"Burrows DJ, McGown A, Jain SA, Felice MD, Ramesh TM, Sharrack B, et al. Animal models of Multiple Sclerosis: from rodents to zebrafish. Mult Scler. 2019;25(3):306\u201324. https:\/\/doi.org\/10.1177\/1352458518805246.","journal-title":"Mult Scler"},{"issue":"4","key":"1133_CR12","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","volume":"164","author":"CS Constantinescu","year":"2011","unstructured":"Constantinescu CS, Farooqi N, O\u2019Brien K, Gran B. Experimental autoimmune Encephalomyelitis (EAE) as a model for Multiple Sclerosis (MS). Br J Pharmacol. 2011;164(4):1079\u2013106. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01302.x.","journal-title":"Br J Pharmacol"},{"issue":"12","key":"1133_CR13","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nri3095","volume":"11","author":"KHG Mills","year":"2011","unstructured":"Mills KHG. TLR-Dependent T cell activation in autoimmunity. Nat Rev Immunol. 2011;11(12):807\u201322. https:\/\/doi.org\/10.1038\/nri3095.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"1133_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1155\/2009\/325847","volume":"26","author":"GG Ortiz","year":"2009","unstructured":"Ortiz GG, Mac\u00edas-Islas M\u00c1, Pacheco-Mois\u00e9s FP, Cruz-Ramos JA, Sustersik S, Barba EA, et al. Oxidative stress is increased in Serum from Mexican patients with relapsing-remitting Multiple Sclerosis. Disease Markers. 2009;26(1):35\u201339. https:\/\/doi.org\/10.1155\/2009\/325847.","journal-title":"Disease Markers"},{"key":"1133_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/961863","volume":"2014","author":"M Gironi","year":"2014","unstructured":"Gironi M, Borgiani B, Mariani E, Cursano C, Mendozzi L, Cavarretta R, et al. Oxidative stress is differentially present in Multiple Sclerosis courses, early evident, and unrelated to treatment. J Immunol Res 2014. 2014;2014:1\u20139. https:\/\/doi.org\/10.1155\/2014\/961863.","journal-title":"J Immunol Res 2014"},{"key":"1133_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/708659","volume":"2013","author":"GG Ortiz","year":"2013","unstructured":"Ortiz GG, Pacheco-Mois\u00e9s FP, Bitzer-Quintero OK, Ram\u00edrez-Anguiano AC, Flores-Alvarado LJ, Ram\u00edrez-Ram\u00edrez V, et al. Immunology and oxidative stress in Multiple Sclerosis: clinical and Basic approach. Clin Dev Immunol 2013. 2013;2013:1\u201314. https:\/\/doi.org\/10.1155\/2013\/708659.","journal-title":"Clin Dev Immunol 2013"},{"issue":"2","key":"1133_CR17","doi-asserted-by":"publisher","first-page":"155932581876145","DOI":"10.1177\/1559325818761455","volume":"16","author":"T Farkhondeh","year":"2018","unstructured":"Farkhondeh T, Samarghandian S, Shahri AMP, Samini F. The neuroprotective effects of Thymoquinone: a Review. Dose Response. 2018;16(2):1559325818761455. https:\/\/doi.org\/10.1177\/1559325818761455.","journal-title":"Dose Response"},{"issue":"1","key":"1133_CR18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.2174\/1871529X18666180212114816","volume":"18","author":"H Shaterzadeh-Yazdi","year":"2018","unstructured":"Shaterzadeh-Yazdi H, Noorbakhsh M-F, Hayati F, Samarghandian S, Farkhondeh T. Immunomodulatory and anti-inflammatory effects of Thymoquinone. CHDDT. 2018, February;18(1):52\u201360. https:\/\/doi.org\/10.2174\/1871529X18666180212114816.","journal-title":"CHDDT"},{"key":"1133_CR19","doi-asserted-by":"publisher","first-page":"111157","DOI":"10.1016\/j.biopha.2020.111157","volume":"134","author":"MY Ali","year":"2021","unstructured":"Ali MY, Akter Z, Mei Z, Zheng M, Tania M, Khan MA. Thymoquinone in autoimmune Diseases: therapeutic potential and molecular mechanisms. Biomed Pharmacother. 2021;134 (November 2020): 111157. https:\/\/doi.org\/10.1016\/j.biopha.2020.111157.","journal-title":"Biomed Pharmacother"},{"key":"1133_CR20","doi-asserted-by":"publisher","unstructured":"Khan A. Antioxidant and anti-inflammatory action of Thymoquinone. Mol Ther Actions Thymoquinone: Actions Thymoquinone. 2018, April.41\u201356. https:\/\/doi.org\/10.1007\/978-981-10-8800-1_4\/TABLES\/1.","DOI":"10.1007\/978-981-10-8800-1_4\/TABLES\/1"},{"issue":"January","key":"1133_CR21","first-page":"388","volume":"41","author":"A Mohamed","year":"2005","unstructured":"Mohamed A, Afridi DM, Garani O, Tucci M. Thymoquinone inhibits the activation of NF-KappaB in the brain and spinal cord of Experimental autoimmune Encephalomyelitis. Biomed Sci Instrum. 2005;41(January):388\u201393. https:\/\/europepmc.org\/article\/med\/15850137.","journal-title":"Biomed Sci Instrum"},{"issue":"1","key":"1133_CR22","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41392-023-01654-7","volume":"8","author":"B Xu","year":"2023","unstructured":"Xu B, Li S, Shi R, Liu H. Multifunctional mesoporous silica nanoparticles for biomedical applications\u201c. Sig Transduct Target Ther. 2023;8(1):435. https:\/\/doi.org\/10.1038\/s41392-023-01654-7.","journal-title":"Sig Transduct Target Ther"},{"issue":"17","key":"1133_CR23","doi-asserted-by":"publisher","first-page":"15322","DOI":"10.1021\/acsami.9b02797","volume":"11","author":"CS Cheng","year":"2019","unstructured":"Cheng CS, Liu TP, Chien FC, Mou CY, Wu SH, Chen YP. Codelivery of plasmid and curcumin with Mesoporous silica nanoparticles for promoting neurite outgrowth. ACS Appl Mater Interface. 2019;11(17):15322\u201331. https:\/\/doi.org\/10.1021\/acsami.9b02797.","journal-title":"ACS Appl Mater Interface"},{"issue":"12","key":"1133_CR24","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/ADMA.201104763","volume":"24","author":"F Tang","year":"2012","unstructured":"Tang F, Li L, Chen D. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery. Adv Mater. 2012;24(12):1504\u201334. https:\/\/doi.org\/10.1002\/ADMA.201104763.","journal-title":"Adv Mater"},{"issue":"1\u20132","key":"1133_CR25","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/J.IJPHARM.2016.09.042","volume":"513","author":"S Lungare","year":"2016","unstructured":"Lungare S, Hallam K, Badhan RKS. Phytochemical-loaded Mesoporous silica nanoparticles for nose-to-brain olfactory drug delivery. Int J Multiling Pharm. 2016;513(1\u20132):280\u201393. https:\/\/doi.org\/10.1016\/J.IJPHARM.2016.09.042.","journal-title":"Int J Multiling Pharm"},{"issue":"8","key":"1133_CR26","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1021\/acs.molpharmaceut.6b00190","volume":"13","author":"R Elle","year":"2016","unstructured":"Elle R, Rahmani SR, Lauret C, Morena M, Bidel LPR, Boulahtouf A, et al. Functionalized Mesoporous silica Nanoparticle with antioxidants as a New Carrier that generates lower oxidative stress Impact on cells. Mol. Pharm. 2016;13(8):2647\u201360. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6b00190.","journal-title":"Mol. Pharm"},{"key":"1133_CR27","doi-asserted-by":"publisher","unstructured":"Baghirov H, Karaman D, Viitala T, Duchanoy A, Lou YR, Mamaeva V, et al. Feasibility study of the permeability and uptake of Mesoporous silica nanoparticles across the blood-brain Barrier. PLoS One. 2016;11(8):e0160705. https:\/\/doi.org\/10.1371\/journal.pone.0160705.","DOI":"10.1371\/journal.pone.0160705"},{"issue":"July","key":"1133_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/J.BRAINRESBULL.2020.03.018","volume":"160","author":"S Harilal","year":"2020","unstructured":"Harilal S, Jose J, Parambi DGT, Kumar R, Unnikrishnan MK, Uddin MS, et al. Revisiting the blood-brain Barrier: a hard nut to crack in the transportation of drug molecules. Brain Res Bull. 2020;160(July):121\u201340. https:\/\/doi.org\/10.1016\/J.BRAINRESBULL.2020.03.018.","journal-title":"Brain Res Bull"},{"issue":"May","key":"1133_CR29","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/J.MICROMESO.2014.02.003","volume":"190","author":"N Elbialy","year":"2014","unstructured":"Elbialy N, Mohamed N, Monem AS. Synthesis, characterization and application of Gold nanoshells using Mesoporous silica core. Microporous Mesoporous Mater. 2014;190(May):197\u2013207. https:\/\/doi.org\/10.1016\/J.MICROMESO.2014.02.003.","journal-title":"Microporous Mesoporous Mater"},{"issue":"35","key":"1133_CR30","doi-asserted-by":"publisher","first-page":"20118","DOI":"10.1039\/C9RA02907A","volume":"9","author":"M Fahmy","year":"2019","unstructured":"Fahmy M, Mosleh AM, Elghany AA, Shams-Eldin E, Serea ES, Ali SA, et al. Coated silver nanoparticles: synthesis, cytotoxicity, and optical properties. RSC Adv. 2019;9(35):20118\u201336. https:\/\/doi.org\/10.1039\/C9RA02907A.","journal-title":"RSC Adv"},{"issue":"1\u20132","key":"1133_CR31","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/J.IJPHARM.2018.03.037","volume":"543","author":"J Tu","year":"2018","unstructured":"Tu J, Bussmann J, Du G, Gao Y, Bouwstra JA, Kros A. Lipid bilayer-coated Mesoporous silica nanoparticles carrying bovine hemoglobin towards an erythrocyte mimic. Int J Multiling Pharm. 2018;543(1\u20132):169\u201378. https:\/\/doi.org\/10.1016\/J.IJPHARM.2018.03.037.","journal-title":"Int J Multiling Pharm"},{"key":"1133_CR32","doi-asserted-by":"publisher","unstructured":"Aharoni R, Schottlender N, Bar-Lev DD, Eilam R, Sela M, Tsoory M, et al. Cognitive impairment in an Animal model of Multiple Sclerosis and its Amelioration by Glatiramer Acetate. Sci Rep. 2019;9 (9(1):1\u201315. https:\/\/doi.org\/10.1038\/s41598-019-40713-4.","DOI":"10.1038\/s41598-019-40713-4"},{"issue":"1","key":"1133_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/0471142735.im1501s88","volume":"88","author":"SD Miller","year":"2010","unstructured":"Miller SD, Karpus WJ, Davidson TS. Experimental autoimmune encephalomyelitis in the mouse. CP Immunol. 2010;88(1):15\u20131. https:\/\/doi.org\/10.1002\/0471142735.im1501s88.","journal-title":"CP Immunol"},{"issue":"6","key":"1133_CR34","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1093\/CLINCHEM\/41.6.892","volume":"41","author":"H Moshage","year":"1995","unstructured":"Moshage H, Kok B, Huizenga JR, Jansen PL. Nitrite and nitrate determinations in plasma: a Critical evaluation. Clin Chem. 1995;41(6):892\u201396. https:\/\/doi.org\/10.1093\/CLINCHEM\/41.6.892.","journal-title":"Clin Chem"},{"issue":"6","key":"1133_CR35","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/0039-128X(94)90006-X","volume":"59","author":"M Ruiz-Larrea","year":"1994","unstructured":"Ruiz-Larrea M, Ma AML, Liza M, Lacort M, de Groot H. Antioxidant effects of estradiol and 2-hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsomes. Steroids. 1994;59(6):383\u201388. https:\/\/doi.org\/10.1016\/0039-128X(94)90006-X.","journal-title":"Steroids"},{"issue":"1","key":"1133_CR36","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","volume":"82","author":"GL Ellman","year":"1959","unstructured":"Ellman GL. Tissue sulfhydryl groups. Archives Biochem Biophys. 1959;82(1):70\u201377. https:\/\/doi.org\/10.1016\/0003-9861(59)90090-6.","journal-title":"Archives Biochem Biophys"},{"issue":"C","key":"1133_CR37","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0076-6879(84)05016-3","volume":"105","author":"H Aebi","year":"1984","unstructured":"Aebi H. Catalase in vitro. Methods Enzymol. 1984;105(C):121\u201326. https:\/\/doi.org\/10.1016\/S0076-6879(84)05016-3.","journal-title":"Methods Enzymol"},{"key":"1133_CR38","unstructured":"Suvarna KS, Layton C, Bancroft JD. Bancroft\u2019s theory and practice of histological techniques, 8th ed. Elsevier Health Sciences; 2018. 584 p."},{"issue":"2","key":"1133_CR39","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11011-015-9750-5","volume":"31","author":"S Mir","year":"2016","unstructured":"Mir S, Ali F, Chauhan D, Arora R, Khan HA. Accumulation of reactivity to MBP sensitizes TRAIL Mediated oligodendrocyte Apoptosis in adult sub cortical white matter in a model for human Multiple Sclerosis. Metab Brain Dis. 2016;31(2):299\u2013309. https:\/\/doi.org\/10.1007\/s11011-015-9750-5.","journal-title":"Metab Brain Dis"},{"key":"1133_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-60761-303-9_1\/TABLES\/2","volume":"42","author":"TD Gould","year":"2009","unstructured":"Gould TD, Dao DT, Kovacsics CE. The open field test. Neuromethods. 2009;42:1\u201320. https:\/\/doi.org\/10.1007\/978-1-60761-303-9_1\/TABLES\/2.","journal-title":"Neuromethods"},{"issue":"March","key":"1133_CR41","doi-asserted-by":"publisher","first-page":"108999","DOI":"10.1016\/J.JNEUMETH.2020.108999","volume":"351","author":"R Aharoni","year":"2021","unstructured":"Aharoni R, Globerman R, Eilam R, Brenner O, Arnon R. Titration of myelin oligodendrocyte glycoprotein (MOG) - induced Experimental autoimmune Encephalomyelitis (EAE) model. J Neurosci Methods. 2021;351(March):108999. https:\/\/doi.org\/10.1016\/J.JNEUMETH.2020.108999.","journal-title":"J Neurosci Methods"},{"key":"1133_CR42","doi-asserted-by":"publisher","unstructured":"Pitarokoili K, Ambrosius B, Gold R. Lewis rat model of Experimental autoimmune Encephalomyelitis. CP Neurosci. 2017;81(1):.9.61.1\u20139.61.20. https:\/\/doi.org\/10.1002\/CPNS.36.","DOI":"10.1002\/CPNS.36"},{"issue":"4","key":"1133_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11051-021-05218-0","volume":"23","author":"E Ortega","year":"2021","unstructured":"Ortega E, Blanco S, Ruiz A, Peinado M\u00c1, Peralta S, Morales ME. Lipid nanoparticles for the transport of drugs like dopamine through the blood-brain Barrier. J Nanopart Res. 2021;23(4):1\u201311. https:\/\/doi.org\/10.1007\/s11051-021-05218-0.","journal-title":"J Nanopart Res"},{"issue":"1","key":"1133_CR44","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0165-5728(99)00257-X","volume":"104","author":"Y Pollak","year":"2000","unstructured":"Pollak Y, Ovadia H, Goshen I, Gurevich R, Monsa K, Avitsur R, et al. Behavioral aspects of Experimental autoimmune Encephalomyelitis. J Neuroimmunol. 2000;104(1):31\u201336. https:\/\/doi.org\/10.1016\/S0165-5728(99)00257-X.","journal-title":"J Neuroimmunol"},{"issue":"1\u20132","key":"1133_CR45","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S0165-5728(03)00073-0","volume":"137","author":"Y Pollak","year":"2003","unstructured":"Pollak Y. The EAE-associated behavioral syndrome II. Modulation by anti-inflammatory treatments. J Neuroimmunol. 2003;137(1\u20132):100\u201308. https:\/\/doi.org\/10.1016\/S0165-5728(03)00073-0.","journal-title":"J Neuroimmunol"},{"issue":"January","key":"1133_CR46","doi-asserted-by":"publisher","first-page":"40","DOI":"10.52319\/j.nanoscitec.2021.a5","volume":"1","author":"Z Jafari","year":"2021","unstructured":"Jafari Z. Mesoporous silica nanoparticles as versatile Carrier platforms in therapeutic Applications. J Educ Chang Nanosci Technol. 2021;1(January):40\u201362. https:\/\/doi.org\/10.52319\/j.nanoscitec.2021.a5.","journal-title":"J Educ Chang Nanosci Technol"},{"issue":"3","key":"1133_CR47","first-page":"130","volume":"42","author":"EA Datau","year":"2010","unstructured":"Datau EA, Wardhana W, Surachmanto EE, Pandelaki JA, Langi, Langi JA, et al. Efficacy of Nigella Sativa on Serum free testosterone and Metabolic disturbances in central Obese male. Acta Med Indones. 2010;42(3):130\u201334. https:\/\/europepmc.org\/article\/med\/20724766.","journal-title":"Acta Med Indones"},{"key":"1133_CR48","doi-asserted-by":"publisher","first-page":"102653","DOI":"10.1016\/J.CTIM.2020.102653","volume":"57","author":"S Safi","year":"2021","unstructured":"Safi S, Razmpoosh E, Fallahzadeh H, Mazaheri M, Abdollahi N, Nazari M, et al. The effect of Nigella Sativa on appetite, anthropometric and body composition indices among overweight and Obese women: a crossover, Double-blind, placebo-controlled, randomized clinical trial. Complement Ther Med. 2021, March;57:102653. https:\/\/doi.org\/10.1016\/J.CTIM.2020.102653.","journal-title":"Complement Ther Med"},{"issue":"2","key":"1133_CR49","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/J.EXPNEUROL.2012.07.010","volume":"237","author":"N Haji","year":"2012","unstructured":"Haji N, Mandolesi G, Gentile A, Sacchetti L, Fresegna D, Rossi S, et al. TNF-\u03b1-Mediated anxiety in a mouse model of Multiple Sclerosis. Exp Neurol. 2012;237(2):296\u2013303. https:\/\/doi.org\/10.1016\/J.EXPNEUROL.2012.07.010.","journal-title":"Exp Neurol"},{"key":"1133_CR50","doi-asserted-by":"publisher","unstructured":"Firdaus F, Zafeer MF, Ahmad M, Afzal M. Anxiolytic and anti-inflammatory Role of Thymoquinone in arsenic-induced Hippocampal toxicity in Wistar rats. Heliyon. 2018;4(6):e00650. https:\/\/doi.org\/10.1016\/J.HELIYON.2018.E00650.","DOI":"10.1016\/J.HELIYON.2018.E00650"},{"issue":"1\u20132","key":"1133_CR51","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1515\/REVNEURO.2006.17.1-2.111","volume":"17","author":"C Lever","year":"2006","unstructured":"Lever C, Burton S, \u039f\u2019keefe J. Rearing on Hind legs, environmental Novelty, and the Hippocampal formation. Rev Neurosci. 2006;17(1\u20132):111\u201333. https:\/\/doi.org\/10.1515\/REVNEURO.2006.17.1-2.111.","journal-title":"Rev Neurosci"},{"issue":"3","key":"1133_CR52","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1037\/0033-2909.83.3.482","volume":"83","author":"RN Walsh","year":"1976","unstructured":"Walsh RN, Cummins RA. The open-field test: a Critical Review. Psychological Bull. 1976;83(3):482\u2013504. https:\/\/doi.org\/10.1037\/0033-2909.83.3.482.","journal-title":"Psychological Bull"},{"issue":"February","key":"1133_CR53","doi-asserted-by":"publisher","first-page":"135617","DOI":"10.1016\/J.NEULET.2020.135617","volume":"745","author":"S Hajipour","year":"2021","unstructured":"Hajipour S, Farbood Y, Dianat M, Rashno M, Khorsandi LS, Sarkaki A. Thymoquinone improves Behavioral and Biochemical deficits in hepatic encephalopathy induced by thioacetamide in rats. Neurosci Lett. 2021;745(February):135617. https:\/\/doi.org\/10.1016\/J.NEULET.2020.135617.","journal-title":"Neurosci Lett"},{"issue":"1","key":"1133_CR54","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1006\/ANBE.1995.0221","volume":"50","author":"A Moyaho","year":"1995","unstructured":"Moyaho A, Eguibar JR, Diaz JL. Induced grooming transitions and open field Behaviour differ in high- and low-yawning sublines of sprague-dawley rats. Anim Behaviour. 1995;50(1):61\u201372. https:\/\/doi.org\/10.1006\/ANBE.1995.0221.","journal-title":"Anim Behaviour"},{"issue":"4","key":"1133_CR55","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0163-1047(79)90362-5","volume":"25","author":"J Jolles","year":"1979","unstructured":"Jolles J, Rompa-Barendregt J, Gispen WH. Novelty and grooming behavior in the rat. Behav Neural Biol. 1979;25(4):563\u201372. https:\/\/doi.org\/10.1016\/S0163-1047(79)90362-5.","journal-title":"Behav Neural Biol"},{"issue":"1\u20132","key":"1133_CR56","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/0003-3472(59)90025-9","volume":"7","author":"G Doyle","year":"1959","unstructured":"Doyle G, Yule EP. Grooming activities and Freezing Behaviour in relation to Emotionality in albino rats. Anim Behaviour. 1959;7(1\u20132):18\u201322. https:\/\/doi.org\/10.1016\/0003-3472(59)90025-9.","journal-title":"Anim Behaviour"},{"issue":"February","key":"1133_CR57","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/J.COBEHA.2017.12.013","volume":"19","author":"MS Fanselow","year":"2018","unstructured":"Fanselow MS. Emotion, motivation and function. Curr Opin Behavioral Sci. 2018;19(February):105\u201309. https:\/\/doi.org\/10.1016\/J.COBEHA.2017.12.013.","journal-title":"Curr Opin Behavioral Sci"},{"issue":"2","key":"1133_CR58","doi-asserted-by":"publisher","first-page":"28","DOI":"10.5923\/j.neuroscience.20170602.02","volume":"6","author":"SJ Bagi","year":"2017","unstructured":"Bagi SJ, Daniel EE, Rabiu KM, Ezekiel I, Sulaiman SO. Effect of oral administration of some selected sweeteners on anxiety in Wistar rat model. Res Neurosci. 2017;6(2):28\u201334. https:\/\/doi.org\/10.5923\/j.neuroscience.20170602.02.","journal-title":"Res Neurosci"},{"issue":"3","key":"1133_CR59","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1037\/h0071444","volume":"18","author":"CS Hall","year":"1934","unstructured":"Hall CS. Emotional behavior in the rat. I. Defecation and urination as measures of individual differences in Emotionality. J Comp Psychol. 1934;18(3):385\u2013403. https:\/\/psycnet.apa.org\/record\/1935-01733-001.","journal-title":"J Comp Psychol"},{"issue":"5","key":"1133_CR60","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s11062-012-9235-7","volume":"43","author":"MD Svanidze","year":"2012","unstructured":"Svanidze MD, Bukiya NG, Butskhrikidze MP. Effect of oxytocin on the Emotional state and behavior of rats under stress conditions. Neurophysiology. 2012;43(5):365\u201368. https:\/\/doi.org\/10.1007\/s11062-012-9235-7.","journal-title":"Neurophysiology"},{"key":"1133_CR61","doi-asserted-by":"publisher","first-page":"411","DOI":"10.2147\/JIR.S258991","volume":"13","author":"S Hemmati","year":"2020","unstructured":"Hemmati S, Sadeghi M, Yousefi-Manesh H, Eslamiyeh M, Vafaei A, Foroutani L, et al. Protective effects of Leukadherin1 in a rat model of Targeted Experimental autoimmune Encephalomyelitis (EAE): possible Role of P47phox and MDA downregulation\u201d. JIR 13: 411\u201320 https:\/\/doi.org\/10.2147\/JIR.S258991. 2020.","journal-title":"JIR"},{"issue":"4","key":"1133_CR62","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/S1474-4422(02)00102-3","volume":"1","author":"KJ Smith","year":"2002","unstructured":"Smith KJ, Lassmann H. The Role of Nitric oxide in Multiple Sclerosis. The Lancet Neurol. 2002;1(4):232\u201341. https:\/\/doi.org\/10.1016\/S1474-4422(02)00102-3.","journal-title":"The Lancet Neurol"},{"issue":"9\u201310","key":"1133_CR63","first-page":"453","volume":"57","author":"S Gawe\u0142","year":"2004","unstructured":"Gawe\u0142 S, Wardas M, Niedworok E, Wardas P. Malondialdehyde (MDA) as a lipid peroxidation Marker. Wiad Lek (Warsaw, Pol: 1960). 2004;57(9\u201310):453\u201355.","journal-title":"Wiad Lek (Warsaw, Pol: 1960)"},{"issue":"36","key":"1133_CR64","doi-asserted-by":"publisher","first-page":"11919","DOI":"10.1523\/JNEUROSCI.0652-14.2014","volume":"34","author":"M Arruda-Carvalho","year":"2014","unstructured":"Arruda-Carvalho M, Restivo L, Guskjolen A, Epp JR, Elgersma Y, Josselyn SA, et al. Conditional deletion of \u03b1-CaMKII impairs integration of adult-generated granule cells into dentate gyrus circuits and hippocampus-Dependent learning. J Neurosci. 2014;34(36):11919\u201328. https:\/\/doi.org\/10.1523\/JNEUROSCI.0652-14.2014.","journal-title":"J Neurosci"},{"issue":"1","key":"1133_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.6000\/2369-3355.2017.04.01.1","volume":"4","author":"A Parveen","year":"2017","unstructured":"Parveen A, Potluri A, Kuila D, Mills D. Osteoblast behavior on Silicon and porous-Silicon substrates. J Coat Sci Technol. 2017;4(1):1\u201312. https:\/\/doi.org\/10.6000\/2369-3355.2017.04.01.1.","journal-title":"J Coat Sci Technol"},{"key":"1133_CR66","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1016\/j.biopha.2018.11.093","volume":"109","author":"WG Hozayen","year":"2019","unstructured":"Hozayen WG, Mahmoud AM, Desouky EM, El-Nahass E-S, Soliman HA, Farghali AA. Cardiac and pulmonary toxicity of Mesoporous silica nanoparticles is associated with excessive ROS production and redox imbalance in Wistar rats. Biomed Pharmacother. 2019;109:2527\u201338. https:\/\/doi.org\/10.1016\/j.biopha.2018.11.093.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"1133_CR67","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1039\/c5ra17517h","volume":"6","author":"M Zhou","year":"2016","unstructured":"Zhou M, Xie L, Fang CJ, Yang H, Wang YJ, Zhen XY, et al. Implications for blood-brain-Barrier permeability, in vitro oxidative stress and neurotoxicity potential induced by Mesoporous silica nanoparticles: effects of surface modification. RSC Adv. 2016;6(4):2800\u201309. https:\/\/doi.org\/10.1039\/c5ra17517h.","journal-title":"RSC Adv"},{"issue":"9","key":"1133_CR68","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.bcp.2009.12.015","volume":"79","author":"M Alhosin","year":"2010","unstructured":"Alhosin M, Abusnina A, Achour M, Sharif T, Muller C, Peluso J, et al. Induction of Apoptosis by Thymoquinone in lymphoblastic leukemia jurkat cells is Mediated by a P73-Dependent pathway which Targets the epigenetic integrator UHRF1. Biochemical Pharmacol. 2010;79(9):1251\u201360. https:\/\/doi.org\/10.1016\/j.bcp.2009.12.015.","journal-title":"Biochemical Pharmacol"},{"issue":"6","key":"1133_CR69","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1258\/ebm.2010.009369","volume":"235","author":"PS Koka","year":"2010","unstructured":"Koka PS, Mondal D, Schultz M, Abdel-Mageed AB, Agrawal KC. Studies on molecular mechanisms of growth inhibitory effects of Thymoquinone against prostate cancer cells: role of reactive oxygen Species. Exp Biol Med (Maywood). 2010;235(6):751\u201360. https:\/\/doi.org\/10.1258\/ebm.2010.009369.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"2","key":"1133_CR70","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s10495-009-0421-z","volume":"15","author":"N El-Najjar","year":"2010","unstructured":"El-Najjar N, Chatila M, Moukadem H, Vuorela H, Ocker M, Gandesiri M, et al. Reactive oxygen Species mediate Thymoquinone-induced Apoptosis and activate ERK and JNK signaling. Apoptosis. 2010;15(2):183\u201395. https:\/\/doi.org\/10.1007\/s10495-009-0421-z.","journal-title":"Apoptosis"},{"key":"1133_CR71","first-page":"274","volume":"45","author":"A Mohamed","year":"2009","unstructured":"Mohamed A, Waris HM, Ramadan H, Quereshi M, Kalra J. Amelioration of chronic relapsing Experimental autoimmune Encephalomyelitis (cr-eae) using Thymoquinone - Biomed 2009. Biomed Sci Instrum. 2009;45:274\u201379. http:\/\/europepmc.org\/abstract\/MED\/19369775.","journal-title":"Biomed Sci Instrum"},{"key":"1133_CR72","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.neuint.2015.01.008","volume":"82","author":"AP Mazzetti","year":"2015","unstructured":"Mazzetti AP, Fiorile MC, Primavera A, Bello ML. Glutathione transferases and Neurodegenerative Diseases. Neurochemistry Int. 2015;82:10\u201318. https:\/\/doi.org\/10.1016\/j.neuint.2015.01.008.","journal-title":"Neurochemistry Int"},{"issue":"4","key":"1133_CR73","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10522-007-9085-7","volume":"8","author":"T Kishido","year":"2007","unstructured":"Kishido T, Unno K, Yoshida H, Choba D, Fukutomi R, Asahina S, et al. Decline in Glutathione peroxidase activity is a reason for brain senescence: consumption of Green tea catechin prevents the decline in its activity and protein oxidative damage in ageing mouse brain. Biogerontology. 2007;8(4):423\u201330. https:\/\/doi.org\/10.1007\/s10522-007-9085-7.","journal-title":"Biogerontology"},{"issue":"2","key":"1133_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biom11020165","volume":"11","author":"A Alrafiah","year":"2021","unstructured":"Alrafiah A. Thymoquinone protects neurons in the cerebellum of rats through mitigating oxidative stress and inflammation following high-fat diet supplementation. Biomolecules. 2021;11(2):1\u201311. https:\/\/doi.org\/10.3390\/biom11020165.","journal-title":"Biomolecules"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-026-01133-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-026-01133-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-026-01133-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T09:07:06Z","timestamp":1788167226000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40360-026-01133-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1133"],"URL":"https:\/\/doi.org\/10.1186\/s40360-026-01133-z","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]},"assertion":[{"value":"16 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Institutional Animal Ethics Committee authorized the in vivo protocol. Number: (\n                      CU-I-F-28\u201321\n                      ). This study\u2019s animal procedures followed the ARRIVE guidelines and relevant restrictions. Informed consent did not apply. \u201cThe Institutional Animal Care and Use Committee (CU-IACUC), Cairo University\u201d accepted all experimental protocols.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NA.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"119"}}